Acadia Pharmaceuticals buy Deutsche Bank Aktiengesellschaft
Start price
21.05.25
/
50%
€19.69
Target price
21.05.26
€30.98
Performance (%)
6.12%
Price
24.02.26
€20.89
Summary
This prediction is currently active. With a performance of 6.12%, the BUY prediction by Deutsche_Bank_Aktien for Acadia Pharmaceuticals is trending in the right direction. This prediction currently runs until 21.05.26. The prediction end date can be changed by Deutsche_Bank_Aktien at any time. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 7.903% | 7.903% |
| iShares Core DAX® | 0,02 % | 0,58 % |
| iShares Nasdaq 100 | 1,74 % | -2,06 % |
| iShares Nikkei 225® | 0,43 % | 10,49 % |
| iShares S&P 500 | 1,33 % | 0,14 % |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft to $35.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat